Table 1.
Characteristics of the Patients and Creatinine Outcome 30 Days Postoperative in the Pre-C and C-Groups
| Pre-C Group (n=19) | C-Group (n=15) | P value | |
|---|---|---|---|
| Sex donor | 10 female (52.6%) | 7 female (46.7%) | 1.000 |
| 9 male (47.4%) | 8 male (53.3%) | ||
| Age donor, y | 50.9 ± 11.8 | 54.7 ± 10.6 | .3323 |
| BMI donor | 29.2 ± 6.5 kg/m2 | 25.1 ± 10.6 kg/m2 | .0315 |
| Sex recipient | 7 female (36.8%) | 4 female (26.7%) | .7152 |
| 12 male (63.2%) | 11 male (73.3%) | ||
| Age recipient, y | 53.1 ± 12.9 | 55.4 ± 10.4 | .5710 |
| BMI recipient | 25.8 ± 4.3 kg/m2 | 25.8 ± 4.7 kg/m2 | .9667 |
| ASA-Score | 2:0 | 2:1 (6.7%) | .4412 |
| 3:17 (89.5%) | 3:12 (80.0%) | .6343 | |
| 4:2 (10.5%) | 4:2 (13.3%) | 1.000 | |
| Previous pulmonary diseases | 5 (26.3%) | 2 (13.3%) | .4263 |
| Tx-type | .4513 | ||
| Living donation | 7 (36.8%) | 3 (20%) | |
| Postmortem | 12 (63.3%) | 12 (80%) | |
| Immunosuppression with Prograf, CellCept, Decortin | 19 (100%) | 15 (100%) | 1.000 |
| Immunotherapy induction | |||
| No | 3 (15.8%) | 1 (6.7%) | .6128 |
| Simulect | 9 (47.4%) | 11 (73.3%) | .1706 |
| Antithymozytenglobulin | 6 (31.6%) | 3 (20%) | .6974 |
| Eculizumab | 1 (5.3%) | 0 | 1.000 |
| Cold ischemia time, min | 395.5 ± 260.8 | 532.2 ± 349.8 | .2007 |
| Warm ischemia time, min | 25.9±8.8 | 24.7 ± 10.7 | .7299 |
| CMV status donor | .4764 | ||
| Negative | 8 (42.1%) | 4 (26.7%) | |
| Positive | 11 (57.9%) | 11 (73.3%) | |
| CMV recipient | .4764 | ||
| Negative | 8 (42.1%) | 4 (26.7%) | |
| Positive | 11 (57.9%) | 11 (73.3%) | |
| HLA mismatch | 2.47 ± 1.31 | 2.4 ± 1.5 | .8795 |
| Panel reactive antibodies | |||
| 0-5 | 14 (73.7%) | 8 (53.3%) | .2883 |
| 6-84 | 3 (15.8%) | 6 (40.0%) | .1392 |
| ≥85 | 2 (10.5%) | 1 (6.7%) | 1.000 |
| Postoperative blood transfusion | 0.74 ± 1.19 | 0.6 ± 0.83 | .7084 |
| Creatinine in serum 30 d posttransplantation | 2.05 ± 1.99 (0.86-9.97) | 1.49 ± 0.45 (0.912.71) | .2949 |
Data are n (%). P values are estimated 2-tailed Fisher exact test for categorical data.
Abbreviations: ASA-score, Classification of the American Society of Anesthesiologists; BMI, body mass index; C-group, corona group; CMV, cytomegalovirus; pre-C group, pre-corona group; Tx, transplantation.